Detalles de la búsqueda
1.
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.
Blood
; 143(21): 2178-2189, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38394665
2.
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
; 135(17): 1438-1446, 2020 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32315382
3.
Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(2): e29387, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648216
4.
Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols.
Haematologica
; 106(4): 1198-1201, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646890
5.
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.
Blood
; 122(15): 2622-9, 2013 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23974192
6.
The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.
Haematologica
; 100(1): 62-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25304613
7.
Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
Haematologica
; 100(12): 1564-70, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405155
8.
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
Haematologica
; 99(11): 1716-21, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25150254
9.
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.
J Clin Oncol
; 42(14): 1676-1686, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306592
10.
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
Blood Adv
; 8(8): 1835-1845, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386975
11.
Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
Blood Adv
; 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621200
12.
A multidimensional analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in the bone marrow of pediatric acute myeloid leukemia.
medRxiv
; 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37961528
13.
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.
J Clin Oncol
; 41(16): 2963-2974, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996387
14.
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.
medRxiv
; 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986997
15.
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort.
Hemasphere
; 6(1): e668, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964038
16.
Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms.
Cancer Discov
; 12(8): 1860-1872, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678530
17.
Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015.
Leukemia
; 35(4): 1001-1011, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32820270
18.
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
Lancet Haematol
; 8(10): e700-e710, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560013
19.
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
Lancet Haematol
; 8(1): e55-e66, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357483
20.
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
J Bone Miner Res
; 36(12): 2290-2299, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34610647